Understanding ALOX12P2: A Potential Drug Target Or Biomarker (G245)

Target Name: ALOX12P2

NCBI ID: G245

ALOX12P2

Other Name(s): Arachidonate 12-lipoxygenase pseudogene 2, transcript variant 1 | arachidonate 12-lipoxygenase pseudogene 2 | ALOX12P2 variant 1 | ALOX12E

Understanding ALOX12P2: A Potential Drug Target Or Biomarker

ALOX12P2, also known as Arachidonate 12-lipoxygenase pseudogene 2, is a gene that has been identified as a potential drug target or biomarker. The gene is located on chromosome 16 and encodes a protein known as ALOX12P2, which is involved in the production of arachidonic acid, a pro-inflammatory compound that has been linked to a number of diseases, including cardiovascular disease and inflammatory disorders.

In recent years, researchers have been increasingly interested in investigating the role of ALOX12P2 in human disease, and have identified a number of potential drug targets based on its involvement in inflammation and cellular signaling. One of the most promising aspects of this gene is its potential as a drug target, as it has been shown to be involved in a wide range of cellular processes that are associated with inflammation and disease.

One of the key functions of ALOX12P2 is its role in the production of arachidonic acid, which is a pro-inflammatory compound that is involved in the regulation of many cellular processes, including inflammation, immune response, and cell signaling. Arachidonic acid has been shown to play a key role in the development of inflammatory diseases, including heart failure, cancer, and autoimmune disorders.

In addition to its role in inflammation, ALOX12P2 has also been shown to be involved in a number of other cellular processes that are important for human health. For example, it has been shown to be involved in the regulation of cell signaling, including the production of signaling molecules known as cytokines and chemokines. ALOX12P2 has also been shown to be involved in the regulation of cell division and growth, as well as in the regulation of cellular processes that are important for tissue repair and regeneration.

Given its involvement in a wide range of cellular processes that are important for human health, ALOX12P2 has been identified as a potential drug target or biomarker for a wide range of diseases. For example, it has been shown to be involved in the development of inflammatory diseases, including heart failure, cancer, and autoimmune disorders, and has been identified as a potential target for small molecules, antibodies, and other therapeutic agents.

In addition to its potential as a drug target or biomarker, ALOX12P2 has also been shown to be an attractive potential therapeutic agent for a number of other purposes. For example, it has been shown to be involved in the regulation of cytokine production and has been shown to have anti-inflammatory effects in cell cultures. In addition, ALOX12P2 has been shown to be involved in the regulation of cell division and growth, which has potential implications for the development of cancer therapies.

Overall, ALOX12P2 is a gene that has been identified as a potential drug target or biomarker for a wide range of diseases. Its involvement in the production of arachidonic acid and its involvement in a wide range of cellular processes that are important for human health make it an attractive potential therapeutic agent for a number of diseases. Further research is needed to fully understand the role of ALOX12P2 in human disease and to develop effective therapies based on this gene.

Protein Name: Arachidonate 12-lipoxygenase Pseudogene 2

The "ALOX12P2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ALOX12P2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets